Overall, from the results of our in vitro kinase assays, phosphorylation expression, and in silico binding affinity, we confirmed that MBP-11901 targeted FLT3, VEGFR2, c-KIT, and PDGFRβ in HCC (Figure 7G). The gene discussed is MBP; the disease is hepatocellular carcinoma.